Critical medicines ambition vs revision; EMA launches #ItTakesATeam campaign on medicine shortages; GLP-1 leaders Novo Nordisk and Eli Lilly cut deals with Trump; COVID-19 infection poses a greater risk of vascular disorders in children than vaccination; and, Europe’s beating cancer plan assessed